Month: July 2021

Verkkokauppa.com Oyj Stock Exchange Release 16 July 2021 at 7:45 am EEST Verkkokauppa.com decided on the second installment of the quarterly dividend The Board of Directors of Verkkokauppa.com Oyj has decided today, on the basis of the authorization granted by the Annual General Meeting 2021, that a dividend of EUR 0.058 per share (EUR 2,594,497.70 in total) be distributed from retained earnings. The dividend will be paid to a shareholder registered in the company’s shareholders’ register maintained by Euroclear Finland Ltd on the record date for the dividend on 20 July 2021. The dividend will be paid on 27 July 2021. Verkkokauppa.com’s Annual General Meeting, held on 25 March 2021, resolved to authorize the Board of Directors to decide at its discretion on the distribution of dividends. Based on the authorization, the total amount of...

SAN DIEGO, July 15, 2021 (GLOBE NEWSWIRE) — Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced the pricing of its upsized initial public offering of 18,750,000 shares of common stock at an initial public offering price of $16.00 per share. All of the shares are being offered by Erasca. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Erasca, are expected to be $300.0 million. The shares are expected to begin trading on the Nasdaq Global Select Market on July 16, 2021 under the ticker symbol “ERAS.” The offering is expected to close on July 20, 2021, subject to the satisfaction of customary...

VANCOUVER, British Columbia, July 15, 2021 (GLOBE NEWSWIRE) — Mr. Ashwath Mehra reports that ASTOR Management AG, a company that he controls, purchased today 22,000,000 common shares of Fancamp Exploration Ltd. (“Common Shares”) through the TSX Venture Exchange at $0.11 per share for total consideration paid of $2,420,000. Immediately prior to the purchase of the Common Shares, Mr. Mehra had beneficial ownership and control of 2,750,000 Common Shares, representing 1.6% of the outstanding Common Shares. Mr. Mehra currently has beneficial ownership and control of 24,750,000 Common Shares, representing 14.0% of the outstanding Common Shares. Mr. Mehra has acquired the Common Shares for investment and may acquire additional Common Shares or dispose of Common Shares (through market or private transactions) from time to time. A copy...

MONTREAL, July 15, 2021 (GLOBE NEWSWIRE) — P. Peter Pascali, President and Chief Executive Officer of PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX: PYR) (NASDAQ: PYR) (FRA: 8PY), a high-tech company (hereinafter referred to as the “Company” or “PyroGenesis”), that designs, develops, manufactures and commercializes plasma atomized metal powders, environmentally friendly plasma waste-to-energy systems and clean plasma torch products, has filed today an updated early warning report with respect to his shareholdings in PyroGenesis in connection with his proposed disposition (the “Proposed Disposition”) through the facilities of the Toronto Stock Exchange of up to 765,000 common shares of PyroGenesis (“Common Shares”) held by Fiducie de Crédit Mellon Trust (the “Trust”) under an automatic securities disposition plan (“ASDP”)...

SCOTTSDALE, Ariz., July 15, 2021 (GLOBE NEWSWIRE) — AgJunction Inc. (TSX: AJX), (“AgJunction”), through its wholly-owned subsidiary Novariant, Inc. (“Novariant”), has been chosen by Komatsu Ltd. (“Komatsu”), an industry-leading manufacturer and supplier of equipment for the construction, mining equipment, utilities, forestry and industrial markets to provide sophisticated automation kits for construction workplaces. The contract has been awarded following Novariant’s successful integration of customized autosteering systems for Komatsu’s equipment for agricultural use. Novariant currently provides automation modules that support mapping, path planning, and autosteering for Komatsu’s construction equipment platforms used in agricultural applications. “After the successful integration of the customized autosteering,...

NEW YORK, July 15, 2021 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today presented clinical outcomes from the randomized controlled trial of remestemcel-L in ventilator-dependent COVID-19 patients with moderate/severe acute respiratory distress syndrome (ARDS). Results of respiratory function were highlighted at the biennial Stem Cells, Cell Therapies, and Bioengineering in Lung Biology and Diseases conference hosted by the University of Vermont, Burlington, VT, on July 15. The invited presentation was given by Mesoblast Chief Executive Officer, Dr Silviu Itescu, and materials have been lodged with the ASX. The trial in mechanically ventilated COVID-19 patients with moderate/severe ARDS enrolled 222 patients across the United States, of...

VANCOUVER, British Columbia, July 15, 2021 (GLOBE NEWSWIRE) — A.I.S. Resources Limited (TSXV: AIS, OTCQB: AISSF) (the “Company” or “AIS”) announces that effective July 9, 2021 the Company’s ISIN changed from “BS0014301076” to “CA0014311058”. Concurrently, the Company’s CUSIP changed from “001430107” to “001431105”. The change was due to a change of jurisdiction. There was no change in the Company’s name, no change in its trading symbol and no consolidation of capital. About A.I.S. Resources Limited A.I.S. Resources Limited is a publicly traded investment issuer listed on the TSX Venture Exchange focused on precious and base metals exploration. AIS’ value add strategy is to acquire prospective exploration projects and enhance their value by better defining the mineral resource with a view to attracting joint venture partners...

GRAND CAYMAN, Cayman Islands, July 15, 2021 (GLOBE NEWSWIRE) — Patria Investments Limited, or “Patria” (PAX: NASDAQ), through its affiliated investment funds, announces the completion of the initial public offering of portfolio company SmartFit. The company priced shares at R$23 and began trading on the Brazilian B3 Stock Exchange on July 14th, 2021 under the ticker SMFT3. The listing raised at least R$2.3 billion in a 100% primary offering, with the potential for upsizing through an over-allotment option. SmartFit is the first publicly listed fitness club operator in Latin America and the 5th largest Brazilian IPO in 2021. Patria’s current stake in SmartFit is held in its fifth private equity fund, as well as related co-investment vehicles. Private Equity Fund V is a 2015 vintage fund with $1.8 billion in commitments and 9 portfolio...

TORONTO, July 15, 2021 (GLOBE NEWSWIRE) — SULLIDEN MINING CAPTIAL INC. (“Sulliden” or the “Company”) (TSX: AAB) has acquired 24,720,943 units of Medivolve Inc. (“Medivolve”) (NEO: MEDV) in a non-brokered private placement financing of MEDV at a price of $0.07 per unit for a total subscription price of $1,730,466.01. Each unit is comprised of one Medivolve common share and one Medivolve common share purchase warrant. Each common share purchase warrant is exercisable for one common share of Medivolve at a price of $0.08 for a period of five years. Prior to the closing of the MEDIVOLVE private placement, Sulliden held 215,000 common shares and 2,040,000 warrants, representing approximately 0.1% of MEDIVOLVE’s issued and outstanding common shares and 1% on a partially diluted basis. Subsequent to the closing of MEDIVOLVE’s private...

TORONTO, July 15, 2021 (GLOBE NEWSWIRE) — ABERDEEN INTERNATIONAL INC. (“Aberdeen” or the “Company”) (TSX: AAB) has acquired 24,101,803 units of Medivolve Inc. (“Medivolve”) (NEO: MEDV) in a non-brokered private placement financing of MEDV at a price of $0.07 per unit for a total subscription price of $1,687,126.21. Each unit is comprised of one Medivolve common share and one Medivolve common share purchase warrant. Each common share purchase warrant is exercisable for one common share of Medivolve at a price of $0.08 for a period of five years. Prior to this transaction, Aberdeen did not own Common Shares of MEDIVOLVE. Subsequent to the closing of MEDIVOLVE’s private placement on July 9, 2021, Aberdeen held 24,101,803 Common Shares and 24,101,803 Warrants, representing 6.2% of MEDIVOLVE’s issued and outstanding Common Shares and...